John Martin of Gilead: full interview

Gilead was founded 30 years ago and now the biotech start-up has become a leading US pharmaceutical company behind flu and HIV treatments, Tamiflu and Atripla. Speaking to pharmaceuticals correspondent Andrew Jack, chief executive John Martin expresses his views on drug access for poorer countries, innovation and dividends.